APA (7th ed.) Citation

Yingchun Zhao, Xinglong Liu, Chuanbo Ding, Yan Gu, Wencong Liu, & Wencong Liu. (2021). Dihydromyricetin Reverses Thioacetamide-Induced Liver Fibrosis Through Inhibiting NF-κB-Mediated Inflammation and TGF-β1-Regulated of PI3K/Akt Signaling Pathway. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Yingchun Zhao, Xinglong Liu, Chuanbo Ding, Yan Gu, Wencong Liu, and Wencong Liu. Dihydromyricetin Reverses Thioacetamide-Induced Liver Fibrosis Through Inhibiting NF-κB-Mediated Inflammation and TGF-β1-Regulated of PI3K/Akt Signaling Pathway. Frontiers Media S.A., 2021.

MLA (9th ed.) Citation

Yingchun Zhao, et al. Dihydromyricetin Reverses Thioacetamide-Induced Liver Fibrosis Through Inhibiting NF-κB-Mediated Inflammation and TGF-β1-Regulated of PI3K/Akt Signaling Pathway. Frontiers Media S.A., 2021.